1. Home
  2. ARCH vs RYTM Comparison

ARCH vs RYTM Comparison

Compare ARCH & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCH
  • RYTM
  • Stock Information
  • Founded
  • ARCH 1969
  • RYTM 2008
  • Country
  • ARCH United States
  • RYTM United States
  • Employees
  • ARCH N/A
  • RYTM N/A
  • Industry
  • ARCH Coal Mining
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARCH Energy
  • RYTM Health Care
  • Exchange
  • ARCH Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • ARCH 2.8B
  • RYTM 3.1B
  • IPO Year
  • ARCH 1988
  • RYTM 2017
  • Fundamental
  • Price
  • ARCH $137.61
  • RYTM $56.12
  • Analyst Decision
  • ARCH Buy
  • RYTM Strong Buy
  • Analyst Count
  • ARCH 5
  • RYTM 10
  • Target Price
  • ARCH $173.60
  • RYTM $65.80
  • AVG Volume (30 Days)
  • ARCH 247.2K
  • RYTM 552.7K
  • Earning Date
  • ARCH 02-13-2025
  • RYTM 11-05-2024
  • Dividend Yield
  • ARCH 0.73%
  • RYTM N/A
  • EPS Growth
  • ARCH N/A
  • RYTM N/A
  • EPS
  • ARCH 9.67
  • RYTM N/A
  • Revenue
  • ARCH $2,645,357,000.00
  • RYTM $112,530,000.00
  • Revenue This Year
  • ARCH N/A
  • RYTM $63.64
  • Revenue Next Year
  • ARCH $0.50
  • RYTM $42.98
  • P/E Ratio
  • ARCH $14.25
  • RYTM N/A
  • Revenue Growth
  • ARCH N/A
  • RYTM 81.55
  • 52 Week Low
  • ARCH $116.44
  • RYTM $35.17
  • 52 Week High
  • ARCH $187.60
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • ARCH 22.97
  • RYTM 46.95
  • Support Level
  • ARCH $150.17
  • RYTM $53.39
  • Resistance Level
  • ARCH $156.63
  • RYTM $57.27
  • Average True Range (ATR)
  • ARCH 5.69
  • RYTM 2.32
  • MACD
  • ARCH -2.97
  • RYTM -0.55
  • Stochastic Oscillator
  • ARCH 1.81
  • RYTM 33.21

About ARCH Arch Resources Inc.

Arch Resources Inc is a producer of metallurgical and coking coal. The company sells its coal to power plants, steel mills, and industrial facilities. Its operating segment includes Metallurgical (MET) and Thermal. It generates maximum revenue from the Metallurgical (MET) segment. Geographically, it derives a majority of its revenue from Asia.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

Share on Social Networks: